Bedaquiline Resistance: Why a Tiered Diagnostic Strategy Is the Way Forward Read more EMPE Diagnostics Partners with Interprise to Expand Access to TB Drug Resistance Diagnostics Across Brazil Read more Lessons from Ukraine: Bringing Next-Generation Molecular TB Diagnostics to the Frontlines Read more Tuberculosis Kills More People Than Any Other Infection. Here’s How We’re Building the Company to Change That. Read more Contract Manufacturing: Blending Agility with Speed to Market Read more Uganda’s TB Progress Highlights a Critical Lesson: Diagnostics Need Strong Health Systems Read more The Cost of Silence: Why Early Detection is the Only Way to Stop Ebola Read more Bridging the Global TB Diagnostic Gap: The Clinical Rigor Behind EMPE TBDx Read more Advancing Healthcare Diagnostics: Why Rwanda is the New Frontier for TB Innovation Read more From Innovation to Access: Bridging the Last-Mile Gap in TB Diagnostics Read more Rapid Detection of M. tuberculosis and Its Resistance to Rifampicin and Isoniazid with the mfloDx™ MDR‑TB test Read more Tuberculosis Diagnostics Pipeline Report 2025 Read more 1 2
